Roles of chemokine receptor CX3CR1 in maintaining murine bone homeostasis through the regulation of both osteoblasts and osteoclasts
暂无分享,去创建一个
K. Matsushima | A. Yamaguchi | T. Iimura | S. Ueha | A. Hoshino | Kenji Yamamoto | T. Imai | Masako Ito | S. Hanada
[1] A. Yamaguchi,et al. Increasing participation of sclerostin in postnatal bone development, revealed by three-dimensional immunofluorescence morphometry. , 2012, Bone.
[2] K. Yamana,et al. SP7 Inhibits Osteoblast Differentiation at a Late Stage in Mice , 2012, PloS one.
[3] K. Matsushima,et al. Deficiency of Chemokine Receptor CCR1 Causes Osteopenia Due to Impaired Functions of Osteoclasts and Osteoblasts* , 2010, The Journal of Biological Chemistry.
[4] K. Tsuneyama,et al. Role of CX3CL1/Fractalkine in Osteoclast Differentiation and Bone Resorption1 , 2009, The Journal of Immunology.
[5] H. Takayanagi,et al. Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis , 2009, Nature Medicine.
[6] M. Mack,et al. Estrogen-dependent and C-C chemokine receptor-2–dependent pathways determine osteoclast behavior in osteoporosis , 2009, Nature Medicine.
[7] J. Bernhagen,et al. Macrophage migration inhibitory factor: a noncanonical chemokine important in atherosclerosis. , 2009, Trends in cardiovascular medicine.
[8] M. Ishii,et al. Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis , 2009, Nature.
[9] A. Ludwig,et al. Glial cross-talk by transmembrane chemokines CX3CL1 and CXCL16 , 2008, Journal of Neuroimmunology.
[10] Y. Sheikine,et al. CXCL16/SR-PSOX--a friend or a foe in atherosclerosis? , 2008, Atherosclerosis.
[11] H. Sakurai,et al. RANKL-induced down-regulation of CX3CR1 via PI3K/Akt signaling pathway suppresses Fractalkine/CX3CL1-induced cellular responses in RAW264.7 cells. , 2007, Biochemical and biophysical research communications.
[12] M. Suematsu,et al. Critical Role for CXC Chemokine Ligand 16 (SR-PSOX) in Th1 Response Mediated by NKT Cells1 , 2007, The Journal of Immunology.
[13] L. Qin,et al. Parathyroid Hormone Stimulates Osteoblastic Expression of MCP-1 to Recruit and Increase the Fusion of Pre/Osteoclasts* , 2007, Journal of Biological Chemistry.
[14] P. Croucher,et al. Role of CCR1 and CCR5 in homing and growth of multiple myeloma and in the development of osteolytic lesions: a study in the 5TMM model , 2006, Clinical & Experimental Metastasis.
[15] K. Yamana,et al. Cbfβ regulates Runx2 function isoform-dependently in postnatal bone development , 2006 .
[16] J. Aubin,et al. Chemokine and chemokine receptor expression during colony stimulating factor-1-induced osteoclast differentiation in the toothless osteopetrotic rat: a key role for CCL9 (MIP-1gamma) in osteoclastogenesis in vivo and in vitro. , 2006, Blood.
[17] N. Morrison,et al. Induction of chemokines and chemokine receptors CCR2b and CCR4 in authentic human osteoclasts differentiated with RANKL and osteoclast like cells differentiated by MCP‐1 and RANTES , 2006, Journal of cellular biochemistry.
[18] R. Ransohoff,et al. The many roles of chemokines and chemokine receptors in inflammation. , 2006, The New England journal of medicine.
[19] Hajime Orimo,et al. Multi‐Detector Row CT Imaging of Vertebral Microstructure for Evaluation of Fracture Risk , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[20] W. Han,et al. Chemokine-like factor 1 is a functional ligand for CC chemokine receptor 4 (CCR4) , 2005, Life Sciences.
[21] P. Tak,et al. Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis , 2005, Annals of the rheumatic diseases.
[22] N. Callander,et al. MIP-1α utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells , 2005 .
[23] Hidde L Ploegh,et al. CX3CR1-Mediated Dendritic Cell Access to the Intestinal Lumen and Bacterial Clearance , 2005, Science.
[24] T. Kita,et al. Cell surface‐anchored SR‐PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6‐expressing cells , 2004, Journal of leukocyte biology.
[25] M. de Virgilio,et al. The nuclear protein HMGB1, a new kind of chemokine? , 2003, FEBS letters.
[26] Yingyu Chen,et al. Identification of eight genes encoding chemokine-like factor superfamily members 1-8 (CKLFSF1-8) by in silico cloning and experimental validation. , 2003, Genomics.
[27] J. Deng,et al. The Novel Zinc Finger-Containing Transcription Factor Osterix Is Required for Osteoblast Differentiation and Bone Formation , 2002, Cell.
[28] N. Kanatani,et al. Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures , 2001, The Journal of cell biology.
[29] G. Roodman,et al. Macrophage inflammatory protein-1alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligand. , 2001, Blood.
[30] T. Miyata,et al. Commitment and Differentiation of Osteoclast Precursor Cells by the Sequential Expression of C-Fms and Receptor Activator of Nuclear Factor κb (Rank) Receptors , 1999, The Journal of experimental medicine.
[31] P. Rüegsegger,et al. Direct Three‐Dimensional Morphometric Analysis of Human Cancellous Bone: Microstructural Data from Spine, Femur, Iliac Crest, and Calcaneus , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[32] S B Rosalki,et al. BIOCHEMICAL MARKERS OF BONE TURNOVER , 1998, International journal of clinical practice.
[33] T. Schall,et al. Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion , 1997, Cell.
[34] E. Barrett-Connor,et al. Urinary N-telopeptide levels discriminate normal, osteopenic, and osteoporotic bone mineral density. , 1997, Archives of internal medicine.
[35] Makoto Sato,et al. Targeted Disruption of Cbfa1 Results in a Complete Lack of Bone Formation owing to Maturational Arrest of Osteoblasts , 1997, Cell.
[36] G. Karsenty,et al. Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation , 1997, Cell.
[37] T. Ohishi,et al. Evaluation of bone turnover in postmenopause, vertebral fracture, and hip fracture using biochemical markers for bone formation and resorption , 1997, Journal of endocrinological investigation.
[38] Wei Wang,et al. A new class of membrane-bound chemokine with a CX3C motif , 1997, Nature.
[39] M. Drezner,et al. Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[40] K. Yamana,et al. Cbf beta regulates Runx2 function isoform-dependently in postnatal bone development. , 2006, Developmental biology.
[41] N. Callander,et al. MIP-1alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells. , 2005, Experimental hematology.
[42] G. Roodman,et al. Macrophage inflammatory protein-1alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligand. , 2001, Blood.
[43] F. Craig,et al. Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma. , 2000, Blood.